title: Aminooxypentane-RANTES induces CCR3 activation and internalization of CCR3 from the surface of human eosinophils.
abstract: Eosinophils are predominant effector cells in allergic diseases attracted by several CC chemokines into the inflammatory tissue. According to their important role in attracting leukocytes, several kinds of chemokine receptor antagonists have been developed. Therefore, the aim of this study was to investigate the effect of aminooxypentane (AOP)-RANTES on the activation of the CC chemokine receptor 3, CCR3, exemplary on human eosinophils, because they represent the dominant CCR3+ cell type. AOP-RANTES dose-dependently induced an increase of intracellular calcium concentration ([Ca(2+)](i)) and a release of reactive oxygen species, which could be inhibited by pertussis toxin, in human eosinophils from normal nonatopic donors. AOP-RANTES was as effective as RANTES but less effective than eotaxin and eotaxin-2 in the activation of the respiratory burst. Flow-cytometric analyses revealed that eosinophils constitutively expressed the CC chemokine receptors CCR1 and CCR3, whereas CCR5 was not expressed. AOP-RANTES, RANTES, eotaxin and eotaxin-2, but not Met-RANTES, induced a downregulation of CCR3 at 37 degrees C. Reexpression of CCR3 on eosinophils was observed within 120 min. Whereas no differences of CCR3 downregulation and recycling after stimulation with AOP-RANTES, RANTES, eotaxin and eotaxin-2 were found there exists a distinct profile of activity with respect to the activation of the respiratory burst in human eosinophils.
authors: Department of Dermatology and Allergology, Hannover Medical University, Hannover, Germany. elsner@htp-tel.de
authors: J
authors: J
authors: Elsner
authors: Y
authors: Y
authors: Dulkys
authors: D
authors: D
authors: Kimmig
authors: T N
authors: TN
authors: Wells
authors: A E
authors: AE
authors: Proudfoot
authors: A
authors: A
authors: Kapp
mesh_terms: D002478:Cells, Cultured; D054413:Chemokine CCL11; D018946:Chemokine CCL5 / Q000031:analogs & derivatives* / Q000494:pharmacology*; D019742:Chemokines, CC; D016207:Cytokines / Q000494:pharmacology; D015536:Down-Regulation; D004804:Eosinophils / Q000187:drug effects / Q000276:immunology*; D006801:Humans; D037342:Pertussis Toxin; D017382:Reactive Oxygen Species / Q000378:metabolism; D054397:Receptors, CCR3; D019707:Receptors, Chemokine / Q000378:metabolism*; D016897:Respiratory Burst; D010566:Virulence Factors, Bordetella / Q000494:pharmacology
chemical_list: C515456:CCL11 protein, human; C515350:CCR3 protein, human; D054413:Chemokine CCL11; D018946:Chemokine CCL5; D019742:Chemokines, CC; D016207:Cytokines; C108335:RANTES, Met-; D017382:Reactive Oxygen Species; D054397:Receptors, CCR3; D019707:Receptors, Chemokine; D010566:Virulence Factors, Bordetella; C111989:aminooxypentane-RANTES; D037342:Pertussis Toxin